Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura, Kidney International, vol.60, issue.3, p.83146, 2001. ,
DOI : 10.1046/j.1523-1755.2001.060003831.x
URL : http://doi.org/10.1046/j.1523-1755.2001.060003831.x
The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels, Journal of Clinical Apheresis, vol.24, issue.2, p.1248, 1986. ,
DOI : 10.1002/jca.2920030209
Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, The American Journal of Medicine, vol.107, issue.6, p.5739, 1999. ,
DOI : 10.1016/S0002-9343(99)00286-7
IMMUNOSUPPRESSION AND PLASMA-EXCHANGE IN THE TREATMENT OF GOODPASTURE'S SYNDROME, The Lancet, vol.307, issue.7962, p.7115, 1976. ,
DOI : 10.1016/S0140-6736(76)93089-0
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue, Journal of Clinical Apheresis, vol.28, issue.3, p.145284, 2013. ,
DOI : 10.1002/jca.21276
Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience, Vox Sanguinis, vol.20, issue.2, p.1616, 2014. ,
DOI : 10.1111/vox.12090
Complications of therapeutic plasma exchange: A prospective study of 1,727 procedures, Journal of Clinical Apheresis, vol.46, issue.5, p.2706, 2007. ,
DOI : 10.1002/jca.20143
Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome, Transfusion, vol.13, issue.8, p.896901, 2000. ,
DOI : 10.1056/NEJM199812313392708
Frequency of immediate adverse effects associated with therapeutic apheresis, Transfusion, vol.16, issue.3, p.2828, 1999. ,
DOI : 10.1046/j.1537-2995.1999.39399219285.x
Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial Off Peer-Rev, oct, vol.9, issue.5, p.3915, 2005. ,
Role of replacement fluids in the immediate complications of plasma exchange. French Registry Cooperative Group, Intensive Care Med. mai, vol.24, issue.5, p.4528, 1998. ,
Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014, Transfusion, vol.54, issue.12, p.32579, 2014. ,
DOI : 10.1111/trf.12917
Predictors of complications in therapeutic plasma exchange, Journal of Clinical Apheresis, vol.335, issue.6, p.22531, 2009. ,
DOI : 10.1002/jca.20217
Plasmapheresis: technique, complications and indications. Rev Médicale Suisse. 5 mars, pp.5812-588, 2008. ,
H??maph??r??se th??rapeutique adulte et p??diatrique, R??animation, vol.14, issue.7, pp.641-650, 2005. ,
DOI : 10.1016/j.reaurg.2005.10.002
Plasma exchange Ann Fr Anesthèsie Rèanimation, p.28491, 1984. ,
Therapeutic plasma exchange : methods and indications, Hématologie, vol.18, issue.1, pp.51-59, 2012. ,
Central Vein Catheter-Related Thrombosis in Intensive Care Patients, Chest, vol.114, issue.1, p.20713, 1998. ,
DOI : 10.1378/chest.114.1.207
Profound ionized hypomagnesemia induced by therapeutic plasma exchange in liver failure patients, Transfusion, vol.61, issue.12, p.1598602, 2002. ,
DOI : 10.1038/sj.bmt.1702472
A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group, N Engl J Med. 23 avr, vol.326, issue.17, p.11239, 1992. ,
Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, shamcontrolled , cross-over study, Brain J Neurol. août, vol.119, p.105566, 1996. ,
Plasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy, New England Journal of Medicine, vol.314, issue.8, p.4615, 1986. ,
DOI : 10.1056/NEJM198602203140801
Plasma Exchange in Polyneuropathy Associated with Monoclonal Gammopathy of Undetermined Significance, New England Journal of Medicine, vol.325, issue.21, p.14826, 1991. ,
DOI : 10.1056/NEJM199111213252105
Evidence-based guideline update: Plasmapheresis in neurologic disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, vol.76, issue.3, p.294300, 2011. ,
DOI : 10.1212/WNL.0b013e318207b1f6
Échanges plasmatiques en réanimation. Conférences d'actualisation, pp.533-575, 1996. ,
Comparative effects of plasma exchange and pyridostigmine on respiratory muscle strength and breathing pattern in patients with myasthenia gravis., Thorax, vol.50, issue.10, p.10806, 1995. ,
DOI : 10.1136/thx.50.10.1080
Comparative analysis of therapeutic options used for myasthenia gravis, Annals of Neurology, vol.7, issue.1, p.797805, 2010. ,
DOI : 10.1002/ana.22139
A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis, Journal of Clinical Apheresis, vol.33, issue.6, p.34755, 2011. ,
DOI : 10.1002/jca.20317
Surgical outcome in thymic tumors with myasthenia gravis after plasmapheresis - a comparative study, Interactive CardioVascular and Thoracic Surgery, vol.7, issue.6, p.100710, 2008. ,
DOI : 10.1510/icvts.2007.170894
Beneficial effects of plasmapheresis before thymectomy on the outcome in myasthenia gravis, The Japanese Journal of Thoracic and Cardiovascular Surgery, vol.11, issue.1, p.27, 2005. ,
DOI : 10.1007/s11748-005-1001-y
Doubleblind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis, Neurology. sept, vol.39, issue.9, p.11439, 1989. ,
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease, Annals of Neurology, vol.44, issue.6, p.87886, 1999. ,
DOI : 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q
Plasma exchange for severe attacks of CNS demyelination: Predictors of response, Neurology, vol.58, issue.1, p.1436, 2002. ,
DOI : 10.1212/WNL.58.1.143
[Severe bouts of neuromyelitis optica: dramatic improvement after plasma exchanges], Rev Neurol, vol.165, issue.5, p.47981, 2009. ,
Treatment of Waldenstr??m's Macroglobulinemia by Plasmapheresis, New England Journal of Medicine, vol.263, issue.12, p.5749, 1960. ,
DOI : 10.1056/NEJM196009222631202
Plasmapheresis therapy in macroglobulinemia, Ann Intern Med. mai, vol.58, p.789800, 1963. ,
Plasma exchange in acute and chronic hyperviscosity syndrome: a rheological approach and guidelines study, Ann DellIstituto Super Sanità, vol.43, issue.2, p.1715, 2007. ,
Evidence-based focused review of management of hyperviscosity syndrome, Blood, vol.119, issue.10, p.22058, 2012. ,
DOI : 10.1182/blood-2011-04-347690
Hyperviscosity syndrome in plasma cell dyscrasias, Semin Thromb Hemost. oct, vol.29, issue.5, p.46771, 2003. ,
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines, Mayo Clin Proc. sept, vol.85, issue.9, p.82433, 2010. ,
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains, Kidney International, vol.73, issue.11, p.12828, 2008. ,
DOI : 10.1038/ki.2008.108
Aggregation of gamma-G3 proteins: relevance to the hyperviscosity syndrome, J Clin Invest. mars, vol.49, issue.3, p.61021, 1970. ,
The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgGrheumatoid factors, Arthritis Rheum. avr, vol.18, issue.2, p.97106, 1975. ,
Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura. Presse Médicale Paris Fr 1983, mars, vol.41, p.16376, 2012. ,
Acute Neurological Involvement in Diarrhea-Associated Hemolytic Uremic Syndrome, Clinical Journal of the American Society of Nephrology, vol.5, issue.7, p.121828, 2010. ,
DOI : 10.2215/CJN.08921209
Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study, The Lancet, vol.378, issue.9796, p.108993, 2011. ,
DOI : 10.1016/S0140-6736(11)61145-8
Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection, American Journal of Transplantation, vol.359, issue.5 Pt 1, p.1099107, 2009. ,
DOI : 10.1111/j.1600-6143.2009.02591.x
Successful Rescue Therapy with Plasmapheresis and Intravenous Immunoglobulin for Acute Humoral Renal Transplant Rejection, Transplantation, vol.78, issue.5, p.7724, 2004. ,
DOI : 10.1097/01.TP.0000128194.55934.48
Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection, Transplantation. 15 mai, vol.75, issue.9, p.14905, 2003. ,
Intravenous Immunoglobulin and Plasmapheresis in Acute Humoral Rejection: Experience in Renal Allograft Transplantation, Human Immunology, vol.66, issue.4, p.3508, 2005. ,
DOI : 10.1016/j.humimm.2005.01.028
A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody, American Journal of Transplantation, vol.3, issue.5, p.34651, 2006. ,
DOI : 10.1097/01.TP.0000112934.12622.2B
Desensitization in HLA-Incompatible Kidney Recipients and Survival, New England Journal of Medicine, vol.365, issue.4, p.31826, 2011. ,
DOI : 10.1056/NEJMoa1012376
ABOincompatible kidney transplantation using both A2 and non-A2 living donors, Transplantation. 15 avr, vol.75, issue.7, p.9717, 2003. ,
DOI : 10.1097/01.tp.0000058226.39732.32
Long-term results of ABO-incompatible living kidney transplantation: a single-center experience, Transplantation. 27 janv, vol.65, issue.2, p.2248, 1998. ,
Plasma exchange conditioning for ABO-incompatible renal transplantation, Journal of Clinical Apheresis, vol.341, issue.2, p.7985, 2004. ,
DOI : 10.1002/jca.20002
Successful Kidney Transplantation After Desensitization Using Plasmapheresis, Low-Dose Intravenous Immunoglobulin, and Rituximab in Highly Sensitized Patients: A Single-Center Experience, Transplantation Proceedings, vol.44, issue.1, 2003. ,
DOI : 10.1016/j.transproceed.2011.11.040
Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation, The Lancet, vol.348, issue.9036, p.120811, 1996. ,
DOI : 10.1016/S0140-6736(96)03452-6
Long-Term Outcome of Anti???Glomerular Basement Membrane Antibody Disease Treated with Plasma Exchange and Immunosuppression, Annals of Internal Medicine, vol.134, issue.11, p.103342, 2001. ,
DOI : 10.7326/0003-4819-134-11-200106050-00009
Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis, American Journal of Kidney Diseases, vol.42, issue.6, p.114953, 2003. ,
DOI : 10.1053/j.ajkd.2003.08.015
Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study, Clin Nephrol. janv, vol.29, issue.1, p.18, 1988. ,
A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group, Am J Kidney Dis Off J Natl Kidney Found. sept, vol.20, issue.3, p.2619, 1992. ,
Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies, Kidney International, vol.40, issue.4, p.75763, 1991. ,
DOI : 10.1038/ki.1991.272
Treatment of rapidly progressive glomerulonephritis by plasma exchange and methylprednisolone pulses. A prospective randomized trial of cyclophosphamide. Interim analysis. The French Cooperative Group, Prog Clin Biol Res, vol.337, p.2637, 1990. ,
Pathophysiology of ANCA-associated vasculitides]. Presse Médicale Paris Fr, oct, vol.41, issue.10, p.9961003, 1983. ,
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis, Journal of the American Society of Nephrology, vol.18, issue.7, p.21808, 2007. ,
DOI : 10.1681/ASN.2007010090
Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis, American Journal of Kidney Diseases, vol.57, issue.4, p.56674, 2011. ,
DOI : 10.1053/j.ajkd.2010.10.049
The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome, Transfusion and Apheresis Science, vol.33, issue.1, p.117, 2005. ,
DOI : 10.1016/j.transci.2004.10.025
A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group, N Engl J Med. 21 mai, vol.326, issue.21, p.13739, 1992. ,
??changes plasmatiques dans les maladies syst??miques??: leur place actuellePlasma exchange: their current place in the treatment of systemic diseases., R??animation, vol.11, issue.5, pp.359-65, 2002. ,
DOI : 10.1016/S1624-0693(02)00256-6
Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature, Autoimmunity Reviews, vol.8, issue.4, p.297301, 2009. ,
DOI : 10.1016/j.autrev.2008.09.002
Catastrophic antiphospholipid syndrome]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, avr, vol.33, issue.4, p.1949, 2012. ,
??changes plasmatiques dans les maladies syst??miques??: leur place actuellePlasma exchange: their current place in the treatment of systemic diseases., R??animation, vol.11, issue.5, pp.359-65, 2002. ,
DOI : 10.1016/S1624-0693(02)00256-6
Plasmapheresis in Immunologic Renal Disease, Blood Purification, vol.33, issue.1-3, 1908. ,
DOI : 10.1159/000334155
Prognostic Factors in Polyarteritis Nodosa and Churg-Strauss Syndrome A Prospective Study in 342 Patients, Medicine, vol.75, issue.1, p.1728, 1996. ,
DOI : 10.1097/00005792-199601000-00003
Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins ,
Plasma exchange in dermatomyositis and polymyositis. Retrospective study of 38 cases of plasma exchange], Ann Médecine Interne, vol.140, issue.6, p.4535, 1989. ,
Therapeutic apheresis for myositises, Transfusion and Apheresis Science, vol.36, issue.2, p.16972, 2007. ,
DOI : 10.1016/j.transci.2007.01.008
Controlled Trial of Plasma Exchange and Leukapheresis in Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.326, issue.21, p.13804, 1992. ,
DOI : 10.1056/NEJM199205213262102
Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS), J Am Coll Cardiol. déc, vol.28, issue.7, p.1696704, 1996. ,
Single Lipoprotein Apheresis Session Improves Cardiac Microvascular Function in Patients With Elevated Lipoprotein(a): Detection by Stress/Rest Perfusion Magnetic Resonance Imaging, Therapeutic Apheresis and Dialysis, vol.71, issue.2, p.12937, 2009. ,
DOI : 10.1111/j.1744-9987.2009.00667.x
Clinical Effects of Direct Adsorption of Lipoprotein Apheresis: Beyond Cholesterol Reduction, Therapeutic Apheresis and Dialysis, vol.6, issue.3, p.3414, 2003. ,
DOI : 10.1002/jca.10010
Treatment of Arteriosclerotic Obstruction by LDL Adsorption, Angiology, vol.44, issue.3, p.2227, 1993. ,
DOI : 10.1177/000331979304400308
Direct Adsorption of Lipoproteins from Whole Blood by DALI Apheresis: Technique and Effects, Therapeutic Apheresis and Dialysis, vol.21, issue.4, p.23943, 2001. ,
DOI : 10.1046/j.1365-2362.1996.2320587.x
Plasma exchange versus an affinity column for cholesterol reduction, Journal of Clinical Apheresis, vol.29, issue.2, p.6974, 1992. ,
DOI : 10.1002/jca.2920070206
Dextran-sulfateadsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipidapheresis--comparison of performance characteristics with DALI and Lipidfiltration, J Clin Apheresis, vol.22, issue.4, p.21523, 2007. ,
Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques, Beitr Zur Infusionstherapie Contrib Infus Ther, vol.23, p.1529, 1988. ,
Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis, Clinical Research in Cardiology Supplements, vol.56, issue.3, p.315, 2012. ,
DOI : 10.1007/s11789-012-0042-x
TREATMENT OF SEVERE DIABETIC HYPERTRIGLYCERID??MIA BY PLASMA EXCHANGE, The Lancet, vol.311, issue.8078, p.1368, 1978. ,
DOI : 10.1016/S0140-6736(78)92450-9
Therapeutic Plasma Exchange in Patients with Chylomicronemia Syndrome Complicated by Acute Pancreatitis, Therapeutic Apheresis and Dialysis, vol.21, issue.3, p.22733, 1999. ,
DOI : 10.1001/jama.265.7.904
Plasmapheresis for severe lipemia: Comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants, Journal of Clinical Apheresis, vol.151, issue.1, p.326, 2003. ,
DOI : 10.1002/jca.10047
Humoral Heart Rejection (Severe Allograft Dysfunction with no Signs of Cellular Rejection or Ischemia): Incidence, Management, and the Value of C4d for Diagnosis, American Journal of Transplantation, vol.12, issue.7, p.25604, 2005. ,
DOI : 10.1097/00007890-199909270-00024
Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation, The Journal of Heart and Lung Transplantation, vol.20, issue.3, p.31621, 2001. ,
DOI : 10.1016/S1053-2498(00)00211-4
Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin, Clinical Transplantation, vol.100, issue.4, p.47684, 2006. ,
DOI : 10.1097/00007890-199609150-00027
Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management, Circulation, vol.131, issue.18, 2015. ,
DOI : 10.1161/CIR.0000000000000093
Complications of therapeutic plasma exchange: A recent assessment, Journal of Clinical Apheresis, vol.16, issue.1, p.15, 1994. ,
DOI : 10.1002/jca.2920090102
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Engl J Med. 8 août, vol.325, issue.6, p.3937, 1991. ,
A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura, Transfusion Medicine, vol.16, issue.Suppl. 95, p.1735, 2007. ,
DOI : 10.1111/j.1365-3148.2006.00720.x
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies, New England Journal of Medicine, vol.349, issue.1, p.3644, 2003. ,
DOI : 10.1056/NEJMoa020286
EULAR recommendations for the management of primary small and medium vessel vasculitis, Annals of the Rheumatic Diseases, vol.68, issue.3 ,
DOI : 10.1136/ard.2008.088096
What are the indications for plasma exchanges in autoimmune diseases?: The registry of the Soci??t?? Fran??aise d???H??maph??r??se, Transfusion and Apheresis Science, vol.36, issue.2, p.1737, 2007. ,
DOI : 10.1016/j.transci.2007.01.007
Drug-induced thrombotic microangiopathy: a systematic review of published reports, Blood, vol.125, issue.4, p.6168, 2015. ,
DOI : 10.1182/blood-2014-11-611335
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma registry and the BloodCenter of Wisconsin, American Journal of Hematology, vol.63, issue.5, 2015. ,
DOI : 10.1002/ajh.23960
Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments, Clin Adv Hematol Oncol HO. sept, vol.12, issue.9, p.56573, 2014. ,
Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Médicale Paris Fr 1983, mars, vol.41, issue.3 2, p.17788, 2012. ,
Effective application of therapeutic plasma exchange in a case of acute dermatomyositis]. Przeglad Lek, p.12301, 2012. ,
Apheresis registry in France: indications, techniques, and complications. French Registry Study Group, Ther Apher Off J Int Soc Apher Jpn Soc Apher. juin, vol.4, issue.3, p.20710, 2000. ,
Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry, Transfusion and Apheresis Science, vol.25, issue.1, p.3341, 2001. ,
DOI : 10.1016/S1473-0502(01)00079-9
Therapeutic apheresis in Sweden: update of epidemiology and adverse events, Transfusion and Apheresis Science, vol.29, issue.2, p.15966, 2003. ,
DOI : 10.1016/S1473-0502(03)00121-6
Experience in therapeutic plasma exchange by membrane filtration at an academic center in Colombia: Registry of the first 500 sessions, Journal of Clinical Apheresis, vol.30, issue.6, 2015. ,
DOI : 10.1002/jca.21391
Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?, Transfusion Medicine, vol.43, issue.4, p.26675, 2006. ,
DOI : 10.1046/j.1365-2141.2003.04360.x
Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: Is its decreased protein S activity clinically related to their development of deep venous thromboses?, Journal of Clinical Apheresis, vol.30, issue.3, p.16972, 2000. ,
DOI : 10.1002/1098-1101(2000)15:3<169::AID-JCA2>3.0.CO;2-R
Central venous catheter use, Intensive Care Medicine, vol.28, issue.1, p.117, 2002. ,
DOI : 10.1007/s00134-001-1154-9
Central venous catheter use, Intensive Care Medicine, vol.28, issue.1, p.1828, 2002. ,
DOI : 10.1007/s00134-001-1156-7
Complications infectieuses des maladies systémiques/ Infections in systemic rheumatic diseases, pp.621-628622, 2005. ,
Management of non infectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey, Blood, vol.119, 2012. ,
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.44, issue.8, pp.1074-1081, 2008. ,
DOI : 10.1002/art.23913
Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus, Arthritis & Rheumatism, vol.32, issue.9, p.147582, 1996. ,
DOI : 10.1002/art.1780390906
Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis, Arthritis Care & Research, vol.63, issue.Suppl, p.35361, 2013. ,
DOI : 10.1002/acr.21812
Systemic corticosteroid treatment and risk of infectious diseases]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, déc, vol.28, issue.12, p.84151, 2007. ,
Risk of Infectious Complications in Patients Taking Glucocorticosteroids, Clinical Infectious Diseases, vol.11, issue.6, p.95463, 1989. ,
DOI : 10.1093/clinids/11.6.954
Immune status and risk for infection in patients receiving chronic immunosuppressive therapy, J Rheumatol. août, vol.32, issue.8, p.147380, 2005. ,
Thrombotic thrombocytopenic purpura treated with plasma exchange or exchange transfusions, West J Med. avr, vol.154, issue.4, p.4103, 1991. ,
Thrombotic Microangiopathy with Targeted Cancer Agents, Clinical Cancer Research, vol.17, issue.18, p.585866, 2011. ,
DOI : 10.1158/1078-0432.CCR-11-0804
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176977
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study, JAMA. 22 déc, vol.270, issue.24, p.295763, 1993. ,
The effect of immunoadsorption with the Immusorba TR-350 column on coagulation compared to plasma exchange, Vox Sanguinis, vol.73, issue.1, p.4651, 2015. ,
DOI : 10.1111/vox.12191
Fibrinogen Reduction and Bleeding Complications in Plasma Exchange, Immunoadsorption and a Combination of the Two, Blood Purification, vol.38, issue.2, p.1606, 2014. ,
DOI : 10.1159/000367682
Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy, Kidney Int févr, vol.64, p.615, 1998. ,
Immunoadsorption (IAS) for systemic lupus erythematosus, Lupus, vol.17, issue.7, p.1159, 2011. ,
DOI : 10.1177/0961203310389487
Immunoadsorption for systemic lupus erythematosus, Atherosclerosis Supplements, vol.10, issue.5, p.1103, 2009. ,
DOI : 10.1016/S1567-5688(09)71823-9
Syndrome catastrophique des anticorps anti-phospholides: intérêt de l'immunoadsorption. La Revue de médecine interne, pp.35-86, 2014. ,
DOI : 10.1016/j.revmed.2014.03.210
L'immunoadsorption: une technique complémentaire prometteuse dans le traitement du purpura thrombocytopénique thrombotique auto-immun réfractaire. 67e congrès de la Société nationale française de médecine interne?5, pp.6-7, 2013. ,
DOI : 10.1016/j.revmed.2013.03.135